BIEL GOES VIRAL - BIGGER THAN "CHICKEN JOCKEY" (the current
BIEL GOES VIRAL - BIGGER THAN "CHICKEN JOCKEY" (the current viral sensation) - if the pps hits .006!
Market cap = $150 million at pps = .006, which would generate massive press (free marketing/advertising) in the news and financial media when they report that the pps increase is equivalent to the gains in Amazon and Apple (3,000% over the past 10 years). It would solve all of BIEL's problems while creating unlimited opportunities for the company. The Reddit crowd would be all over it (generating massive free online marketing/advertising). If the company then declared profits would be used for a share buyback program (after paying off the loans), the pps would soar and the rise would be sustained. As quiet as things have been, BIEL seems to be setting up for a massive run.
BIEL's low cost OEM business model has put the company in position to be profitable soon (if not already) such that if the upcoming annual report confirms:
1) $800k annual revenue - this will be a significant increase from the the $700k-ish reported the previous two years and get the pps out of the trips;
2) $1.5 million annual revenue (or a $400k quarter) - this will likely achieve cash flow positive/profitability and get the pps to copper.
BIEL IS SIMPLE TO ANALYZE!
Q3 2021 was BIEL's only profitable quarter ($22,381) with $414,700 revenue (including $100k+ in covid relief funds). PROFITABILITY IS VERY CLOSE! Seems like $1.5 million annual revenue (or a $400k quarter) should do it, due to BIEL's extremely low operating costs and business model. Then the corresponding pps should hit .01 - and increase .01 for each additional $2.5 million annual revenue (P/E = 100).
BIEL IS THE NEXT AMAZON /APPLE (in terms of ROI)!
When BIEL hits .006, the return on investment for a .0002 buy (for those of us fortunate enough to get them recently) will be about the same as the 10-year ROI (3,000%) for Amazon and Apple (stocks I sold too soon). Microsoft 10-year ROI is ONLY 900%. BIEL can hit .006 in IN THE BLINK OF AN EYE, as $1.5 annual revenue (or a $400k quarter) should do it (due to BIEL's extremely low operating costs and business model). There are many indications that this will be accomplished soon, if it hasn't been already! We know that Taiwan, the VA, South Africa and Bulgaria are in progress, as is RecoveryRx-Veterinary in Europe (with the USA pending). Canada is expanding, New Zealand sales started March 1 and hopefully Australia will soon follow. These new revenue streams should be in addition to the $700k+ earned in each of the past two years.
BioElectronics Corporation (BIEL) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Analyzing Mynd.ai's ADS Ratio Tweak When Mynd.ai decides to shake things up with the American Depositary Shares (ADS) ratio, it's like they're throwing a curveball straight at Wall Street. Listen up, this isn't just a deck shuffle—it's a fundamental tweak that could play a big role in the stock’s perceived value. Starting December 7, 2027, one ADS will leap from...
Continue Reading
Pediatric Dental Challenges Under the Microscope When it comes to kids and dental health, we're talking about the fundamentals—the kind that sticks around and makes a difference in their future pearly whites. None of that flashy tech gizmo stuff, just straight-on strategies for resilient chompers. Cavities, gum irritation, early tooth alignment—these are the everyday...
Continue Reading
Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...
Continue Reading
Securities Trouble on the Horizon: IRTC Takes a Hit Wake up and adjust your seat, folks—iRhythm Technologies (NASDAQ:IRTC) is in the spotlight, and it ain't pretty. Shares nosedived over 30% in a single morning, stirring up quite the murky waters for shareholders. The trigger? A less-than-stellar third-quarter report. The Numbers Don't Lie—Or Do They? Management...
Continue Reading
Labor Standoff at Encore Boston Harbor Ends After a stormy 62 days on the picket lines, around 1,300 workers at Encore Boston Harbor finally find themselves back at their posts, carrying with them the spoils of hard-fought victory. This isn't just a paper contract; it's a banner for worker solidarity. These aren't your run-of-the-mill stock flips, folks; this fight was...
Continue Reading
Kestrel's Financial Rollercoaster Continues Here's the deal with Kestrel Group, folks. They just dropped their Q3 2026 financials, and it's a mixed bag. The top line's looking solid with total revenues hitting $4.8 million, riding high on a 203% jump in Program Services fee income. But dig a little deeper, and there's a $16.4 million net loss staring us in the face....
Continue Reading
An International Celebration: Cultural Connections at CIIE Babies have a way of bringing the world together. Every culture has its own quirks and traditions, but the love for a newborn is common ground. Pigeon gets that, and they're putting it on full display at the China International Import Expo (CIIE) in Shanghai. It's their fourth run at this rodeo, and they’re not...
Continue Reading
UP Fintech's Tumultuous Ride Ever watch a stock tumble and think, "Here we go again?" That's UP Fintech Holding Limited (NASDAQ:TIGR) right now. It's staring down the barrel of a securities fraud class action lawsuit, and trust me, it's messier than yesterday's lunch special. The stock's already gone through the wringer, dropping a hefty 25.34% after some nasty news from...
Continue Reading
A New Chapter for JOYEE N01 There's a moment in every company's life when it either steps boldly into the future or stumbles back into obscurity. For FAW Bestune, October 28, 2026, was one of those defining moments. On this day, they launched global mass production of the JOYEE N01 in Yancheng, China. And boy, did they pull out all the stops—you don't see this kind of...
Continue Reading
Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...
Continue Reading
Top 5 Most Recently Viewed Articles
Understanding the Growth of Cartoning Machines Market As we navigate through the evolving landscape of packaging automation, the cartoning machines market demonstrates a noteworthy trajectory, poised to escalate significantly in the coming years. Currently valued at approximately USD 8.72 billion, research forecasts this market to rise to USD 13.58 billion by 2034. This...
Continue Reading
Overview of the Annual General Meeting Results The Annual General Meeting (AGM) for NB Private Equity Partners Limited has recently concluded, bringing forth significant updates. During the meeting, held for the Class A Shareholders, every resolution on the agenda was passed without any changes, highlighting a unified direction for the company. The resolutions included a...
Continue Reading
Innovative iPad Pilot Program by AltaPointe Health AltaPointe Health has taken a remarkable step in refining how behavioral health crises are managed. In collaboration with MyCare Technologies, local police, and fire-rescue services, they have launched a new pilot program that focuses on reducing non-emergency 911 calls. This initiative is aimed specifically at improving...
Continue Reading
EBLM Supports the Jury's Verdict Every Black Life Matters (EBLM) expresses its support for the jury's not guilty verdict regarding Daniel Penny, emphasizing the importance of protecting others during crises. EBLM believes that rather than punishing individuals for taking action in dangerous situations, the focus should be on addressing the deeper systemic issues that...
Continue Reading
Eden Expands Its Telehealth Services for Female Hormone Therapy Eden has recently launched an innovative telehealth offering that provides women with unprecedented access to hormone replacement therapy (HRT) options. With this development, eligible individuals can consult with licensed healthcare providers across most states in the U.S. to discuss treatment for hormonal...
Continue Reading